Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.
about
Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategiesEpidemiology of colorectal cancerProceedings of the third international molecular pathological epidemiology (MPE) meeting.Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies.Molecular pathological epidemiology gives clues to paradoxical findingsMicroRNA MIR21 and T Cells in Colorectal Cancer.Integration of molecular pathology, epidemiology and social science for global precision medicine.Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.Identification of reference genes for circulating microRNA analysis in colorectal cancer.Decreased preoperative serum 25-Hydroxyvitamin D levels in colorectal cancer are associated with systemic inflammation and serrated morphology.Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma.Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance).Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status.Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges.Effect of antisense microRNA targeting survivin on rectal cancer HRC-9698 cells and its mechanismNutrition, inflammation and cancer.Marine ω-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells.Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrateAssociation Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.The role of vitamin D in hepatic metastases from colorectal cancer.Marine ω-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis.The Role of Vitamin D and Vitamin D Receptors in Colon Cancer.Prognostic value of circulating vitamin D binding protein, total, free and bioavailable 25-hydroxy vitamin D in patients with colorectal cancer.Utility of inverse probability weighting in molecular pathological epidemiology.Colorectal cancer prevention: Immune modulation taking the stage.Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.Molecular backgrounds of ERAP1 downregulation in cervical carcinoma.Vitamin D receptor FokI polymorphism and the risks of colorectal cancer, inflammatory bowel disease, and colorectal adenoma
P2860
Q26776184-26752A7D-6D0E-4A53-85F4-2A56D7C65B44Q28067871-6A0C3256-9F3B-457D-AE65-08742F10D657Q30238962-8FE52F1A-F5BD-4AF2-B455-C519A5B403E7Q30244608-42195C9C-AF99-4392-B2C2-41D6D798C82FQ34621641-59308F21-B3B7-4424-9986-F6390A951D0CQ36173268-DB21D45C-EDCA-4651-87C6-981DB2FED018Q36263645-9B564ABC-43FB-4018-8F10-D392693D8B88Q36264731-65AE63B1-CA92-428C-ADCF-A0DD88B4B92FQ36436728-819654D4-36F0-44A0-BFF4-25899CFCDFE0Q36463854-93D32764-C6F4-4EF4-B7FA-880F9F03208FQ36960938-F713E423-C567-4D30-88D1-60CB3C506EBEQ36968401-56CDF514-FCE9-49EF-92F5-9F14B5DA7F49Q37349084-A6F68622-525A-4440-B445-35FBFC23F33FQ37397201-F47A9D90-C5B7-4F20-B9C2-E6BE266222BEQ37701695-107FAFEF-0032-4101-91C4-CD35BB0776AFQ38379174-54B2774C-BBFE-4D48-8232-24E772D4832EQ38783093-1BC36C21-C649-41B9-B498-9C5F24B90B0DQ38795645-E355AA2C-08DF-4F9A-88BC-ABBC047E9675Q38844651-A36DD52B-19B3-4DFD-8D74-017FCFB597D7Q39443978-2E12BA1D-C482-4C73-83CB-7B79AE4721DBQ39792071-E25D813B-B424-4077-A731-999EEC556DFAQ39869896-E5CBCBCB-BD42-4525-B189-FB7097068E81Q40060444-E65BBB91-1FE7-4B01-9778-71606E0BFBB6Q40085423-234F837A-1A34-4F8D-A645-99DD253E458AQ40642488-EE925B19-163F-4F9A-ABFF-BE7C86376C95Q41070779-0B73A63B-CAF3-43AE-8A11-D50769660940Q41092522-76A9EFED-D424-4C5A-9A05-04C5B359905BQ47271626-BE4E89B5-A1F5-4EA0-9327-3DF048764503Q49391998-ACD7E282-1F2F-4319-ACFB-4FC7AA632A37Q50043586-C27ED6E2-CC1A-42D0-A982-8099021D1BA9Q55437991-3F6B5527-9BBA-415E-A2A7-9FC8EC38300EQ58701309-446807D0-1B24-4470-8FA1-44258BAD399B
P2860
Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Plasma 25-hydroxyvitamin D and ...... ing to tumour immunity status.
@ast
Plasma 25-hydroxyvitamin D and ...... ing to tumour immunity status.
@en
type
label
Plasma 25-hydroxyvitamin D and ...... ing to tumour immunity status.
@ast
Plasma 25-hydroxyvitamin D and ...... ing to tumour immunity status.
@en
prefLabel
Plasma 25-hydroxyvitamin D and ...... ing to tumour immunity status.
@ast
Plasma 25-hydroxyvitamin D and ...... ing to tumour immunity status.
@en
P2093
P2860
P50
P1433
P1476
Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status
@en
P2093
Andrew T Chan
Katsuhiko Nosho
Kosuke Mima
Mingyang Song
Molin Wang
Reiko Nishihara
Xuehong Zhang
P2860
P304
P356
10.1136/GUTJNL-2014-308852
P407
P577
2015-01-15T00:00:00Z